On 22 December 2025, the US Food and Drug Administration (FDA) approved the Wegovy® pill (oral semaglutide 25 mg tablet) as the first oral GLP-1 receptor agonist for chronic weight management. Indica...
Published: 29 Dec 2025
Written by Pooja Vasala
Published: 18 Dec 2025
Written by Avnish Shetty
Written by Sneha Nangare
Published: 17 Dec 2025
Written by Malavika Shylajan
Published: 10 Dec 2025
Written by Azhar Shaikh
Published: 04 Dec 2025
Written by Prateek Chopra
Published: 02 Dec 2025
Published: 01 Dec 2025
Published: 27 Nov 2025
Published: 24 Nov 2025
Published: 21 Nov 2025
Published: 11 Nov 2025
Published: 07 Nov 2025
Published: 31 Oct 2025
Published: 29 Oct 2025
Published: 28 Oct 2025
Published: 27 Oct 2025
Published: 24 Oct 2025
Published: 20 Oct 2025
Published: 16 Oct 2025
Published: 15 Oct 2025
Published: 14 Oct 2025
Published: 13 Oct 2025
Published: 10 Oct 2025
Subscribe to DigimedUpdates for exclusive content and expert insights on all things digital.